India Glycols Limited — PPTs, 18-11-2025: Investor Presentation

Here is the financial summary:

**1. Business Performance:** India Glycols reported strong Q2 & H1 FY26. Q2 Net Revenue grew 14% to ₹1,092 Cr (PAT +31% to ₹65 Cr). H1 Net Revenue rose 11% to ₹2,133 Cr (PAT +26% to ₹138 Cr). Bio-Fuel (up 63% Q2, 55% H1) and Potable Spirits (up 25% Q2, 23% H1) drove growth, offsetting declines in BSPC and Ennature Biopharma.

**2. Growth Drivers or Strategy:** The company plans a major demerger into three focused entities (IGL, IGL Spirits, Ennature Bio Pharma) for value creation. A '3x3' strategy optimizes ethanol sourcing for cost efficiency.

**3. Recent Developments:** The Board approved raising ₹466.99 Cr via a preferential issue of 51.03 lakh shares at ₹915 each, with shareholder approval obtained. A stock split was also completed.

**4. Key Financial Metrics:** Q2 EPS was ₹10.5, H1 EPS ₹22.3. EBITDA for Q2 stood at ₹160 Cr (+33% YoY) and H1 at ₹311 Cr (+25% YoY).

**5. Management Commentary / Outlook:** Management highlighted robust Bio-Fuel growth from expanded capacity for India’s blending program. Potable Spirits is expanding to new markets. BSPC expects continued margin growth, and Ennature Biopharma focuses on branded nutraceuticals.